Your browser doesn't support javascript.
loading
Ubiquitination-mediated degradation of TRDMT1 regulates homologous recombination and therapeutic response.
Zhu, Xiaolan; Wang, Xiangyu; Yan, Wei; Yang, Haibo; Xiang, Yufei; Lv, Fengping; Shi, Yi; Li, Hong-Yu; Lan, Li.
Afiliação
  • Zhu X; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
  • Wang X; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
  • Yan W; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
  • Yang H; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
  • Xiang Y; Department of Cell Biology, University of Pittsburgh, 3501 fifth Ave., Pittsburgh, PA 15260, USA.
  • Lv F; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
  • Shi Y; Department of Cell Biology, University of Pittsburgh, 3501 fifth Ave., Pittsburgh, PA 15260, USA.
  • Li HY; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
  • Lan L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
NAR Cancer ; 3(1): zcab010, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33778494
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NAR Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NAR Cancer Ano de publicação: 2021 Tipo de documento: Article